Rectify’s new lead candidate improves bile composition, reduces inflammation in mice with liver disease October 24, 2024
Interius BioTherapeutics Doses First Patient with in vivo Chimeric Antigen Receptor (CAR) Gene Therapy for B-cell Malignancies October 23, 2024
Rectify Pharma Announces Positive Functional Modulator RTY-694 as Development Candidate for Primary Sclerosing Cholangitis October 23, 2024
Xaira Co-Founder: Nobel Prize in chemistry awarded to three scientists for work on proteins October 9, 2024